Clinical features of 13 HBsAg-negative patients who developed HBV reactivation during the follow-up.

HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; Pt, patient; M, male; F, female; TACE, transarterial chemoembolization; Mono, mono-drug TACE; Combo, combination-drug TACE; RT, radiotherapy; mo, months; UD, undetectable; No, number; Tx, treatment; ALT, alanine aminotransferase; SDH, subdural hemorrhage; PD, progressive disease; FU, follow-up.Clinical features of 13 HBsAg-negative patients who developed HBV reactivation during the follow-up.